Francis Chan, Liangzhu Laboratory, Zhejiang University, China

“In 2026, we celebrate 10 years since the approval of venetoclax—an anticancer drug rooted in basic cell death research. This meeting will unite experts to define the next frontier of cell death science over the coming decade.”

Eicke Latz, German Rheumatology Research Center, DRFZ, Germany

Tanya Kuznetsova, Deputy editor, Cell Reports Medicine, Cell Press

“I am excited about this meeting because it will bring together researchers working on different aspects of Cell Death regulation - starting from fundamental research to drug development and clinical translation. With a wide range of topics and plenty of chances to connect and interact, this Cell Press Symposium will create an environment to exchange ideas and promote collaboration.”

Lucie Laurien, Scientific editor, Cell Reports, Cell Press

“As an editor with a background in cell death research, I’m excited to bring together scientists at this first Cell Press Symposia on programmed cell death. It’s a great chance to share new discoveries and spark connections in a friendly, collaborative environment.”

Sri Narasimhan, Deputy editor, Cell, Cell Press

“The interest in cell death spans more than 150 years, with Cell and Cell Press having published several seminal papers in the field. Yet at present this space is more exciting than ever, as we continue to uncover new forms of cell death and make critical inroads towards drugging various pathways. In this meeting, I look forward to fantastic science, cross-pollination of ideas and scientific collaboration across the world.”